DECIDE: Delphi Expert Consensus Statement on Inflammatory Bowel Disease Dysplasia Shared Management Decision-Making.
Autor: | Kabir M; Division of GI Services, University College London Hospitals NHS Foundation Trust, London, UK.; Department of Surgery and Cancer or Department of Metabolism, Digestion and Reproduction, Imperial College London , London, UK., Thomas-Gibson S; Department of Surgery and Cancer or Department of Metabolism, Digestion and Reproduction, Imperial College London , London, UK.; Department of Gastroenterology or Department of Colorectal Surgery, St Mark's Hospital, London, UK., Tozer PJ; Department of Surgery and Cancer or Department of Metabolism, Digestion and Reproduction, Imperial College London , London, UK.; Department of Gastroenterology or Department of Colorectal Surgery, St Mark's Hospital, London, UK., Warusavitarne J; Department of Surgery and Cancer or Department of Metabolism, Digestion and Reproduction, Imperial College London , London, UK.; Department of Gastroenterology or Department of Colorectal Surgery, St Mark's Hospital, London, UK., Faiz O; Department of Surgery and Cancer or Department of Metabolism, Digestion and Reproduction, Imperial College London , London, UK.; Department of Gastroenterology or Department of Colorectal Surgery, St Mark's Hospital, London, UK., Hart A; Department of Surgery and Cancer or Department of Metabolism, Digestion and Reproduction, Imperial College London , London, UK.; Department of Gastroenterology or Department of Colorectal Surgery, St Mark's Hospital, London, UK., Allison L; Department of Gastroenterology, Royal Free Hospital, London, UK., Acheson AG; Department of Surgery, Nottingham University Hospitals NHS Trust, Nottingham, UK., Atici SD; Department of Surgery, University of Health Sciences Tepecik Training and Research Hospital, Izmir, Turkey., Avery P; Department of Gastroenterology or Department of Colorectal Surgery, St Mark's Hospital, London, UK., Brar M; Department of Surgery, Mount Sinai Hospital, University of Toronto, Toronto, Canada., Carvello M; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; Department of Surgery, IRCCS Humanitas Research Hospital, Milan, Italy., Choy MC; Department of Gastroenterology, Austin Health, Melbourne, VIC, Australia.; Division of Medicine, Dentistry and Health Sciences, University of Melbourne, Austin Academic Centre, Melbourne, VIC, Australia., Dart RJ; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK., Davies J; Department of Gastroenterology, Addenbrooke's Hospital, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Dhar A; Department of Gastroenterology, Darlington Memorial Hospital, County Durham & Darlington NHS Foundation Trust, Darlington, UK.; Department of Gastroenterology, Teesside University, UK, Middlesbrough, UK., Din S; Edinburgh IBD Unit, NHS Lothian, Western General Hospital, Edinburgh, UK., Hayee B; Department of Gastroenterology, King's College Hospital, London, UK., Kandiah K; Department of Gastroenterology, St. George's University Hospitals NHS Foundation Trust, London, UK., Katsanos KH; Division of Gastroenterology, Department of Internal Medicine, University of Ioannina School of Health Sciences, Ioannina, Greece., Lamb CA; Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Gastroenterology, Royal Victoria Infirmary, Newcastle upon Tyne, Newcastle upon Tyne, UK., Limdi JK; Department of Gastroenterology, Northern Care Alliance NHS Foundation Trust, Greater Manchester, UK.; Department of Gastroenterology, University of Manchester , Manchester, UK., Lovegrove RE; Department of Surgery, Worcestershire Acute Hospitals NHS Trust , Worcester, UK., Myrelid P; Department of Surgery, Linköping University Hospital, Linköping, Sweden.; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden., Noor N; Department of Gastroenterology, Cambridge University Hospitals, Addenbrooke's Hospital, Cambridge, UK., Papaconstantinou I; Department of Surgery, Aretaieion Hospital, National and Kapodistrian University of Athens, A thens, Greece., Petrova D; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.; Escuela Andaluza de Salud Pública [EASP], Granada, Spain.; CIBER of Epidemiology and Public Health [CIBERESP], Madrid, Spain., Pavlidis P; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Faculty of Life Sciences and Medicine, King's College London, London, UK., Pinkney T; Department of Surgery, University Hospitals Birmingham, Birmingham, UK., Proud D; Department of Surgery, Austin Health, Heidelberg Victoria, VIC, Australia., Radford S; Department of Surgery, Nottingham University Hospitals NHS Trust, Nottingham, UK., Rao R; Department of Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK., Sebastian S; Department of Gastroenterology, Hull University Teaching Hospitals NHS Trust, Hull, UK., Segal JP; Department of Gastroenterology, Northern Hospital Epping, University of Melbourne, Melbourne, VIC, Australia., Selinger C; Department of Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Spinelli A; Faculty of Life Sciences and Medicine, King's College London, London, UK.; Department of Surgery, University Hospitals Birmingham, Birmingham, UK., Thomas K; Department of Surgery, Nottingham University Hospitals, UK., Wolthuis A; Department of Surgery, University Hospital Leuven, The Netherlands., Wilson A; Department of Surgery and Cancer or Department of Metabolism, Digestion and Reproduction, Imperial College London , London, UK.; Department of Gastroenterology or Department of Colorectal Surgery, St Mark's Hospital, London, UK. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of Crohn's & colitis [J Crohns Colitis] 2023 Nov 08; Vol. 17 (10), pp. 1652-1671. |
DOI: | 10.1093/ecco-jcc/jjad083 |
Abstrakt: | Background and Aims: Inflammatory bowel disease colitis-associated dysplasia is managed with either enhanced surveillance and endoscopic resection or prophylactic surgery. The rate of progression to cancer after a dysplasia diagnosis remains uncertain in many cases and patients have high thresholds for accepting proctocolectomy. Individualised discussion of management options is encouraged to take place between patients and their multidisciplinary teams for best outcomes. We aimed to develop a toolkit to support a structured, multidisciplinary and shared decision-making approach to discussions about dysplasia management options between clinicians and their patients. Methods: Evidence from systematic literature reviews, mixed-methods studies conducted with key stakeholders, and decision-making expert recommendations were consolidated to draft consensus statements by the DECIDE steering group. These were then subjected to an international, multidisciplinary modified electronic Delphi process until an a priori threshold of 80% agreement was achieved to establish consensus for each statement. Results: In all, 31 members [15 gastroenterologists, 14 colorectal surgeons and two nurse specialists] from nine countries formed the Delphi panel. We present the 18 consensus statements generated after two iterative rounds of anonymous voting. Conclusions: By consolidating evidence for best practice using literature review and key stakeholder and decision-making expert consultation, we have developed international consensus recommendations to support health care professionals counselling patients on the management of high cancer risk colitis-associated dysplasia. The final toolkit includes clinician and patient decision aids to facilitate shared decision-making. (© The Author(s) 2023. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |